Alignment Healthcare, Inc.
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
ALHC$7.27-1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(amounts in thousands, except par value and share amounts)
| March 31,2026 | December 31,2025 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $705,584 | $575,817 |
| Accounts receivable (less allowance for credit losses of $0 at March 31, 2026 and $833 at December 31, 2025) | 277,678 | 253,207 |
| Investments - current | 20,707 | 28,413 |
| Prepaid expenses and other current assets | 141,396 | 94,140 |
| Total current assets | 1,145,365 | 951,577 |
| Property and equipment, net | 63,867 | 64,251 |
| Right of use asset, net | 7,073 | 7,019 |
| Goodwill | 32,060 | 32,060 |
| Intangible assets, net | 4,550 | 4,550 |
| Other assets | 8,693 | 6,329 |
| Total assets | $1,261,608 | $1,065,786 |
| Liabilities and Stockholders' Equity | ||
| Current Liabilities: | ||
| Medical expenses payable | $655,967 | $474,569 |
| Accounts payable and accrued expenses | 34,502 | 33,284 |
| Accrued compensation | 34,288 | 49,013 |
| Total current liabilities | 724,757 | 556,866 |
| Long-term debt, net of debt issuance costs | 323,616 | 323,176 |
| Long-term portion of lease liabilities | 6,350 | 6,467 |
| Total liabilities | 1,054,723 | 886,509 |
| Commitments and Contingencies (Note 12) | ||
| Stockholders' Equity: | ||
| Preferred stock, $.001 par value; 100,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 206,671,068 and 204,153,619 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 207 | 205 |
| Additional paid-in capital | 1,204,279 | 1,188,089 |
| Accumulated deficit | (997,601) | (1,009,017) |
| Total stockholders' equity | 206,885 | 179,277 |
| Total liabilities and stockholders' equity | $1,261,608 | $1,065,786 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.